Yibin Yang, PhD
Fox Chase Cancer Center
I completed my Ph.D. training with Dr. Michelle Kelliher at the University of Massachusetts Medical School, studying the ubiquitin-dependent signal transduction pathways. With this foundation, I joined Dr. Louis Staudt’s laboratory at the National Cancer Institute as a research fellow in 2010 to exploit the roles of innate immune signaling and protein ubiquitination machinery in the pathogenesis of Diffuse Large B cell lymphoma. In 2015, I received an NCI Transition Career Development Award to further investigate the roles of immune signaling and protein ubiquitination in lymphoid malignancies. I accepted a tenure track faculty position and started my lab at Fox Chase Cancer Center (FCCC) as an Assistant Professor in May 2016. At FCCC, I decided to shift my studies to the field of Peripheral T-Cell lymphoma and Hodgkin lymphoma, which have minimal available targeted therapy options currently. The main focus of my laboratory is to understand the immune regulatory pathways in these lymphoid malignancies.